Recludix Pharma Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 53

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $21.5M

  • Investors
  • 6

Recludix Pharma General Information

Description

Operator of a drug discovery company intended to treat cancer and autoimmune diseases. The company's platform combines custom DNA-encoded libraries, massively parallel structure-activity relationship profiling, and proprietary selectivity screening tools, enabling pharmaceutical researchers and drug developers to address previously inaccessible protein targets, optimize candidate molecules through iterative design cycles, and advance novel therapies for inflammatory and immune-mediated conditions with improved precision and therapeutic potential.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3010 Science Park Road
  • Suite 200
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3010 Science Park Road
  • Suite 200
  • San Diego, CA 92121
  • United States
+1 (858)

Recludix Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Recludix Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 12-Jan-2026 $21.5M Completed Clinical Trials - General
3. Later Stage VC (Series A) Completed Clinical Trials - General
2. Accelerator/Incubator 11-Mar-2025 $60M Completed Clinical Trials - General
1. Early Stage VC (Series A) 15-Nov-2021 $60M $60M Completed Clinical Trials - General
To view Recludix Pharma’s complete valuation and funding history, request access »

Recludix Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Recludix Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Recludix Pharma Patents

Recludix Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026107062-A1 Stat6 degraders and uses thereof Pending 13-Nov-2024
US-12709628-B2 Stat6 modulators and uses thereof Active 12-Jul-2024
US-20260015373-A1 Stat6 modulators and uses thereof Active 12-Jul-2024
WO-2026015868-A1 Stat6 modulators and uses thereof Pending 12-Jul-2024
WO-2025240354-A1 Methods for screening compounds Pending 13-May-2024 C07K14/4705
To view Recludix Pharma’s complete patent history, request access »

Recludix Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Recludix Pharma Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
Lilly USA Corporation Minority
CONNECT (San Diego) Accelerator/Incubator
Access Biotechnology Corporate Venture Capital Minority
New Enterprise Associates Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Recludix Pharma FAQs

  • When was Recludix Pharma founded?

    Recludix Pharma was founded in 2019.

  • Where is Recludix Pharma headquartered?

    Recludix Pharma is headquartered in San Diego, CA.

  • What is the size of Recludix Pharma?

    Recludix Pharma has 53 total employees.

  • What industry is Recludix Pharma in?

    Recludix Pharma’s primary industry is Drug Discovery.

  • Is Recludix Pharma a private or public company?

    Recludix Pharma is a Private company.

  • What is the current valuation of Recludix Pharma?

    The current valuation of Recludix Pharma is .

  • What is Recludix Pharma’s current revenue?

    The current revenue for Recludix Pharma is .

  • How much funding has Recludix Pharma raised over time?

    Recludix Pharma has raised $123M.

  • Who are Recludix Pharma’s investors?

    Alexandria Venture Investments, Lilly USA, CONNECT (San Diego), Access Biotechnology, and New Enterprise Associates are 5 of 6 investors who have invested in Recludix Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process